We have collected information about Liposomal Drug Delivery System Laboratory Clinic for you. Follow the links to find out details on Liposomal Drug Delivery System Laboratory Clinic.
https://www.ncbi.nlm.nih.gov/pubmed/16519249
This paper reviews the development of the technique for liposomal Amphotericin B (L-Amp-LRC-1, Fungisome) drug delivery system in our laboratory in collaboration with the department of Biochemistry, Delhi University in India and proving the safety and efficacy of this preparation in clinical practice.Author: NA Kshirsagar, SK Pandya, BG Kirodian, S Sanath
https://www.sciencedirect.com/science/article/pii/S0169409X12002980
Drugs that are not weak bases, such as paclitaxel, can be converted to weak base prodrugs thus allowing encapsulation and liposomal retention . Drug release rates have important implications for the therapeutic activities of all types of drug delivery systems, including liposomes.Author: Theresa M. Allen, Pieter R. Cullis
https://www.researchgate.net/publication/7259356_Liposomal_drug_delivery_system_from_laboratory_to_clinic
Liposomal drug delivery system from laboratory to clinic Article · Literature Review in Journal of Postgraduate Medicine 51 Suppl 1(5):S5-15 · February 2005 with 43 Reads How we measure 'reads'
https://tspace.library.utoronto.ca/bitstream/1807/6904/1/jp05126.pdf
Liposomal drug delivery system from laboratory to clinic Kshirsagar NA, Pandya SK,* Kirodian BG,** Sanath S ABSTRACTABSTRACT The main objective of drug delivery systems is to deliver a drug effectively , specifically to the site of action and to achieve greater efficacy and minimise the toxic effects compared to conventional drugs. Amongst variousAuthor: NA Kshirsagar, SK Pandya, BG Kirodian, S Sanath
https://www.naturalmedicinejournal.com/blog/secret-effective-liposomal-delivery
In one study, cellular intake increased 9-fold as the liposome size was decreased from 236 nm to 97 nm, and cellular intake was increased 34-fold at 64 nm. 3 In addition, the therapeutic capabilities of a liposomal delivery system are also related to how fast the body clears the liposomes from the blood.
https://tspace.library.utoronto.ca/handle/1807/6904
This paper reviews the development of the technique for liposomal Amphotericin B (L-Amp-LRC-1, FungisomeTM) drug delivery system in our laboratory in collaboration with the department of Biochemistry, Delhi University in India and proving the safety and efficacy of …Author: NA Kshirsagar, SK Pandya, BG Kirodian, S Sanath
http://www.jpgmonline.com/text.asp?2005/51/5/5/19808
Liposomal drug delivery system from laboratory to clinic. NA Kshirsagar 1, SK Pandya 2, BG Kirodian 3, S Sanath 1 1 Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Parel, India 2 Department of Neurosurgery, Jaslok Hospital, Mumbai, India 3 Abbott Laboratories, Mumbai, India. Correspondence Address: N A Kshirsagar Department of Clinical Pharmacology, Seth GS ...
https://www.researchgate.net/publication/232085760_Liposomal_Drug_Delivery_Systems_From_Concept_to_Clinical_Applications
Liposomal Drug Delivery Systems: From Concept to Clinical Applications. ... From concept to clinical applications ... to the basic liposomal delivery system. Certain types of endocytic. cells, e.g ...
https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/liposomal-drug-delivery
Among many drug delivery systems, liposomal drug delivery is the most extensively investigated in the treatment of topical disorders such as psoriasis, skin cancer, and atopic dermatitis. This delivery approach provides enhanced efficacy and lowered the incidence of side effects as compared with conventional formulations, whereas it also ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664963/
Dec 01, 2015 · Translation of these drug delivery systems into the clinic has not yet been successful, with issues surrounding therapeutic efficacy (e.g., location of diseased tissue and accessibility for remote triggers) and potential toxicity of particularly synthetic components of the drug delivery system (Bibi et al., 2012; Allen and Cullis, 2013 ...Author: Lisa Sercombe, Tejaswi Veerati, Tejaswi Veerati, Fatemeh Moheimani, Sherry Y. Wu, Anil K. Sood, Susa...
Searching for Liposomal Drug Delivery System Laboratory Clinic?
You can just click the links above. The data is collected for you.
